Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ; PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators..

Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.

PMID:
25474533
2.

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.

Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE; PROTECT collaborators.; Canadian Critical Care Trials Group.; Australian and New Zealand Intensive Care Society Clinical Trials Group..

J Crit Care. 2014 Jun;29(3):470.e7-15. doi: 10.1016/j.jcrc.2014.02.004.

PMID:
24726205
3.

Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes.

Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J, Lesur O, Lim W, Fowler R, Lamontagne F, Langevin S, Freitag A, Muscedere J, Friedrich JO, Geerts W, Burry L, Alhashemi J, Cook D; PROTECT collaborators.; Canadian Critical Care Trials Group.; Australian and New Zealand Intensive Care Society Clinical Trials Group..

Chest. 2013 Oct;144(4):1207-15. doi: 10.1378/chest.13-0121.

PMID:
23788287
4.

Heparin-induced thrombocytopenia in medical surgical critical illness.

Warkentin TE, Sheppard JA, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, Mehta S, Davies AR, Bersten AD, Crozier TM, Ernest D, Vlahakis NE, Hall RI, Wood GG, Poirier G, Crowther MA, Cook DJ; Canadian Critical Care Trials Group.; Australian and New Zealand Intensive Care Society Clinical Trials Group..

Chest. 2013 Sep;144(3):848-58. doi: 10.1378/chest.13-0057.

PMID:
23722881
5.

Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences.

Cook D, McDonald E, Smith O, Zytaruk N, Heels-Ansdell D, Watpool I, McArdle T, Matte A, Clarke F, Vallance S, Finfer S, Galt P, Crozier T, Fowler R, Arabi Y, Woolfe C, Orford N, Hall R, Adhikari NK, Ferland MC, Marshall J, Meade M; PROTECT Research Coordinators.; PROTECT Investigators.; Canadian Critical Care Trials Group.; Australian and New Zealand Intensive Care Society Clinical Trials Group..

Crit Care. 2013 Jan 8;17(1):R1. doi: 10.1186/cc11917.

6.

Rates and determinants of informed consent: a case study of an international thromboprophylaxis trial.

Smith OM, McDonald E, Zytaruk N, Foster D, Matte A, Clarke F, Meade L, O'Callaghan N, Vallance S, Galt P, Rajbhandari D, Rocha M, Mehta S, Ferguson ND, Hall R, Fowler R, Burns K, Qushmaq I, Ostermann M, Heels-Ansdell D, Cook D; PROTECT Research Coordinators.; PROTECT Investigators.; Canadian Critical Care Trials Group.; Australian, New Zealand Intensive Care Society Clinical Trials Group..

J Crit Care. 2013 Feb;28(1):28-39. doi: 10.1016/j.jcrc.2012.08.005.

PMID:
23089679
7.

Age of red blood cells and mortality in the critically ill.

Pettilä V, Westbrook AJ, Nichol AD, Bailey MJ, Wood EM, Syres G, Phillips LE, Street A, French C, Murray L, Orford N, Santamaria JD, Bellomo R, Cooper DJ; Blood Observational Study Investigators for ANZICS Clinical Trials Group..

Crit Care. 2011;15(2):R116. doi: 10.1186/cc10142.

8.

Transfusion practice and guidelines in Australian and New Zealand intensive care units.

Blood Observational Study Investigators of ANZICS-Clinical Trials Group., Westbrook A, Pettilä V, Nichol A, Bailey MJ, Syres G, Murray L, Bellomo R, Wood E, Phillips LE, Street A, French C, Orford N, Santamaria J, Cooper DJ.

Intensive Care Med. 2010 Jul;36(7):1138-46. doi: 10.1007/s00134-010-1867-8.

PMID:
20440603
9.

Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.

Robertson MS, Nichol AD, Higgins AM, Bailey MJ, Presneill JJ, Cooper DJ, Webb SA, McArthur C, MacIsaac CM; VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre.; Australian and New Zealand Intensive Care Society Clinical Trials Group..

Crit Care Resusc. 2010 Mar;12(1):9-15.

PMID:
20196708
10.

High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation.

Pilcher DV, Scheinkestel CD, Snell GI, Davey-Quinn A, Bailey MJ, Williams TJ.

J Thorac Cardiovasc Surg. 2005 Apr;129(4):912-8.

11.

Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness.

Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC.

Anaesth Intensive Care. 2001 Oct;29(5):473-8.

12.

Extravascular lung water and acute respiratory distress syndrome--oxygenation and outcome.

Davey-Quinn A, Gedney JA, Whiteley SM, Bellamy MC.

Anaesth Intensive Care. 1999 Aug;27(4):357-62.

Supplemental Content

Loading ...
Support Center